P. A. Vedyapin

P. A. Vedyapin

Auto-generated profile, based on publicly available information

P. A. Vedyapin

Avtsyn Research Institute of Human Morphology «Petrovsky National Research Centre of Surgery»; Infectious diseases hospital No. 2

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in CLINICAL AND EXPERIMENTAL MORPHOLOGY
Verified
Journal Article
Closed access
M2Moscow Infectious Deseases Hospital No. 2
Moscow Infectious Deseases Hospital No. 2
NMN.V. Mozgaleva
N.V. Mozgaleva
YPYu.G. Parkhomenko
Yu.G. Parkhomenko
ACAndrey Chernyaev
Andrey Chernyaev
MSMaria G. Samsonova
Maria G. Samsonova
AMA.I. Mazus
A.I. Mazus
Introduction.The development of the COVID-19 pandemic along with the ongoing pandemic of HIV infection has raised the question of how these two diseases interact. This study examines morphological changes that occur in lung tissue during HIV/SARS-CoV-2 coinfection in patients with varying levels of immune status. Materials and methods. The study included 6 deceased HIV-infected patients who had a clinical diagnosis of COVID-19, which was confirmed postmortem by the detection of SARS-CoV-2 RNA in lung samples obtained during biopsy using polymerase chain reaction. Three patients were with newly diagnosed HIV infection; three patients had a relatively intact immune status (CD4+ more than 200 cells/μl) and no opportunistic infection and received effective antiretroviral therapy. To perform histologic examination, we used histochemical stains by Van Gieson, Grocott, Ziehl-Neelsen, PAS reaction as well as immunohistochemistry (IHC) with antibodies against SARS-CoV-2 nucleocapsid and cytomegalovirus. Results. The macroscopic picture in all cases was characterized by a decreased airiness and compaction of the lung tissue. Microscopically, patients with newly diagnosed HIV demonstrated diffuse alveolar damage (DAD) with pneumocystis pneumonia and cytomegalovirus infection. Nucleocapsid of SARS-CoV-2 was revealed in hyaline membranes and alveolar cells. In patients with controlled HIV, we detected manifestations of various phases of DAD and/or disseminated intravascular coagulation (DIC) syndrome with a predominant distribution of SARS-CoV-2 in macrophages and blood vessels. Conclusion. Lung damage in severe HIV-associated immunodeficiency was determined by the combination of direct cytopathic effect of coronavirus and opportunistic pathogens. In controlled HIV and relatively intact immune status, immune mediated action of SARS-CoV-2 could take place manifesting in diffuse alveolar damage and making the morphological picture comparable to that in HIV-negative patients.

1 January 2022 in CLINICAL AND EXPERIMENTAL MORPHOLOGY
Verified
Journal Article
Open access
YPYu.G. Parkhomenko
Yu.G. Parkhomenko
ACAndrey Chernyaev
Andrey Chernyaev
PVP.A. Vedyapin
P.A. Vedyapin
NMN.V. Mozgaleva
N.V. Mozgaleva
ZOZh.R. Omarova
Zh.R. Omarova
MLMoscow Xema Company Limited
Moscow Xema Company Limited
The COVID-19 pandemic is now a global medical and social problem. Little is known about COVID-19 impact on some vulnerable subgroups, such as immunocompromised patients. Therefore, scientists worldwide show interest in studying the impact of SARS-CoV-2 infection on HIV-positive individuals. We report an autopsy clinical case of a deceased 60-year-old HIV-infected patient with lung damage caused by a combination of the SARS-CoV-2 virus, human herpesvirus 6, cytomegalovirus, and pneumocystis with severe fatal respiratory failure. Keywords: COVID-19, HIV, SARS-CoV-2, herpes virus, cytomegalovirus, pneumocystis, pathological anatomy

1 January 2026 in CLINICAL AND EXPERIMENTAL MORPHOLOGY
Verified
Journal Article
Closed access
PVP.A. Vedyapin
P.A. Vedyapin
MKMaria Kozlova
Maria Kozlova
KMKonstantin Midiber
Konstantin Midiber
NSNikolay K Shakhpazyan
Nikolay K Shakhpazyan
НСНиколай Садыхов
Николай Садыхов
LMLiudmila Mikhaleva
Liudmila Mikhaleva
Introduction. Differential diagnosis of cutaneous manifestations of Kaposi sarcoma and bacillary angiomatosis in HIV-infected patients is particularly challenging in clinical practice. Routine histology may be inconclusive because of overlapping histological features. Materials and methods. We retrospectively analyzed 6 cases of Kaposi sarcoma and 2, of bacillary angiomatosis. Histological, immunohistochemical (HHV-8, CD31, CD34, ERG, and Ki-67), and molecular genetic studies, as well as transmission electron microscopy, were performed. Results. In Kaposi sarcoma, we observed a diffuse proliferation of spindle cells, slit-like vessels, and erythrocyte extravasation. Bacillary angiomatosis showed lobular capillary proliferation with large endothelial cells, neutrophilic infiltration, and necrosis. Immunohistochemistry revealed nuclear expression of HHV-8 only in Kaposi sarcoma, which was confirmed by polymerase chain reaction. Transmission electron microscopy demonstrated ultrastructural differences: Kaposi sarcoma was characterized by thin-walled vessels with a discontinuous basement membrane, absence of Weibel–Palade bodies, and presence of HHV-8 virion aggregates; in bacillary angiomatosis, we detected an intact basement membrane, Weibel–Palade bodies, extracellular bacteria, and neutrophilic infiltration. Conclusion. Immunohistochemical staining for HHV-8 is the most rapid primary method for confirming Kaposi sarcoma. When results are equivocal or polymerase chain reaction is unavailable, transmission electron microscopy may provide a useful diagnostic alternative by enabling direct visualization of viral particles or bacteria. The proposed algorithm improves diagnostic accuracy and facilitates timely administration of etiotropic therapy. Keywords: Kaposi sarcoma, bacillary angiomatosis, HIV-infected patients, differential diagnosis, immunohistochemistry, HHV-8, electron microscopy

1 March 2026 in HIV Infection and Immunosuppressive Disorders
Verified
Journal Article
Open access
PDF file
KMKonstantin Midiber
Konstantin Midiber
LMLiudmila Mikhaleva
Liudmila Mikhaleva
PVP. A. Vedyapin
P. A. Vedyapin
ABA. S. Buchaka
A. S. Buchaka
NSNikolay K Shakhpazyan
Nikolay K Shakhpazyan
АВА. Ю. Вахонин
А. Ю. Вахонин
In this analytical review, the authors present the epidemiology of HIV infection and malignant neoplasms, as well as the relationship between these diseases. At the end of 2023, the total number of people living with HIV was 39.9 million, with 77% of them receiving antiretroviral therapy (ART). With the introduction of ART, the mortality structure among HIV-positive individuals has changed: the incidence of AIDS-defining neoplasms (ADM) has decreased, but the proportion of non-AIDS-defining tumors (nADM) has increased. The main predictors of mortality from nADM are low CD4+ lymphocytes, old age, smoking, and coinfection with viral hepatitis. The epidemiology of colorectal cancer (CRC), which ranks third in incidence among oncological diseases, is considered. CRC most often develops from precancerous lesions such as adenomas and serrated lesions of the colon, and its risk increases with age, obesity, smoking, and low physical activity. Particular attention is paid to the relationship between HIV infection and the development of CRC, as well as the role of viruses such as Epstein-Barr virus and cytomegalovirus in carcinogenesis. HIV infection contributes to the development of chronic inflammatory processes in the colorectal localization, which may increase the risk of developing CRC. Possible mechanisms linking HIV with the development of CRC, including the impact of ART and immunosuppression, are discussed. Potential therapeutic approaches associated with the use of anti-HIV drugs for the treatment of cancer are also considered.